PCSS Surgery for Degenerative Disc Disease
(FUSE Trial)
Trial Summary
What is the purpose of this trial?
This study will evaluate the safety and effectiveness of a device called "Posterior Cervical Stabilization System or PCSS" when used along with posterior cervical fusion (PCF) in combination with anterior cervical discectomy and fusion (ACDF) in the treatment of multi-level cervical degenerative disease.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are using epidural steroids, you must stop at least 14 days before surgery.
What data supports the effectiveness of the treatment Posterior Cervical Stabilization System (PCSS) for Degenerative Disc Disease?
Research on similar treatments, like posterior cervical fusion and decompression, shows that these procedures can improve neck alignment and reduce pain in patients with degenerative disc disorders. This suggests that the Posterior Cervical Stabilization System (PCSS) might also be effective for similar conditions.12345
Is the Posterior Cervical Stabilization System (PCSS) surgery safe for humans?
The Posterior Cervical Stabilization System (PCSS), also known as the cervical pedicle screw (CPS) system, has been shown to be safe in humans, even with the freehand technique. However, surgeries involving the posterior cervical spine, like posterior cervical decompression and fusion, can have complications such as blood loss, infection, and nerve issues, with overall complication rates ranging from 15% to 25%.36789
How is the Posterior Cervical Stabilization System (PCSS) treatment different from other treatments for degenerative disc disease?
The Posterior Cervical Stabilization System (PCSS) is unique because it focuses on stabilizing the spine from the back (posterior approach), which may offer benefits in preserving motion and reducing the risk of adjacent segment disease compared to traditional fusion surgeries. This approach can be less invasive and may be performed in an outpatient setting, potentially leading to quicker recovery times.510111213
Research Team
Matt Jenkins
Principal Investigator
Providence Medical Technology, Inc.
Eligibility Criteria
Adults aged 18-80 with multi-level cervical degenerative disc disease unresponsive to non-surgical treatments, indicated for ACDF between C3-C7. Must be able to follow the study protocol and attend follow-ups. Excludes those with severe obesity, infections, certain previous spine conditions or surgeries, substance abuse issues, mental illness affecting consent or compliance, pregnancy plans within three years, recent investigational drug/device use.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Circumferential Cervical Fusion (CCF) or Anterior Cervical Discectomy and Fusion (ACDF) procedures
Follow-up
Participants are monitored for fusion success and safety outcomes
Extended Follow-up
Participants are monitored for long-term safety and effectiveness
Treatment Details
Interventions
- Posterior Cervical Stabilization System (PCSS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Providence Medical Technology, Inc.
Lead Sponsor